Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Messenger RNA reprogramming by spliceosome-mediated RNA trans-splicing
Mariano A. Garcia-Blanco
Mariano A. Garcia-Blanco
Published August 15, 2003
Citation Information: J Clin Invest. 2003;112(4):474-480. https://doi.org/10.1172/JCI19462.
View: Text | PDF
Perspective Series

Messenger RNA reprogramming by spliceosome-mediated RNA trans-splicing

  • Text
  • PDF
Abstract

In the human genome, the majority of protein-encoding genes are interrupted by introns, which are removed from primary transcripts by a macromolecular enzyme known as the spliceosome. Spliceosomes can constitutively remove all the introns in a primary transcript to yield a fully spliced mRNA or alternatively splice primary transcripts leading to the production of many different mRNAs from one gene. This review examines how spliceosomes can recombine two primary transcripts in trans to reprogram messenger RNAs.

Authors

Mariano A. Garcia-Blanco

×

Total citations by year

Year: 2025 2024 2023 2021 2020 2019 2018 2017 2015 2014 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2000 Total
Citations: 1 1 1 1 2 1 3 3 1 1 2 1 6 4 5 1 4 9 10 3 1 61
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2004 (10)

Title and authors Publication Year
Alpha-1-antitrypsin deficiency: diagnosis and treatment
DH Perlmutter
Clinics in Liver Disease 2004
New high-technology products for the treatment of haemophilia
SW Pipe, JM Saint-Remy, CE Walsh
Haemophilia 2004
Molecular imaging of gene expression in living subjects by spliceosome-mediated RNA trans-splicing
S Bhaumik, Z Walls, M Puttaraju, LG Mitchell, SS Gambhir
Proceedings of the National Academy of Sciences 2004
When proteome meets genome: the alpha helix and the beta strand of proteins are eschewed by mRNA splice junctions and may define the minimal indivisible modules of protein architecture
S Barik
Journal of Biosciences 2004
Trans-splicing repair of CD40 ligand deficiency results in naturally regulated correction of a mouse model of hyper-IgM X-linked immunodeficiency
M Tahara, RG Pergolizzi, H Kobayashi, A Krause, K Luettich, ML Lesser, RG Crystal
Nature Medicine 2004
RNA repair using spliceosome-mediated RNA trans-splicing
SG Mansfield, H Chao, CE Walsh
Trends in Molecular Medicine 2004
New paradigms for gene transfer: RNA trans-splicing and small interfering RNA as therapeutic strategies
Christopher E Walsh
Seminars in Hematology 2004
Molecular Cloning and Characterization of Two Mouse Peroxisome Proliferator-activated Receptor α (PPARα)-regulated Peroxisomal Acyl-CoA Thioesterases
MA Westin, SE Alexson, MC Hunt
The Journal of biological chemistry 2004
Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements
IG Bruno, W Jin, GJ Cote
Human Molecular Genetics 2004
Alternative splicing in disease and therapy
MA Garcia-Blanco, AP Baraniak, EL Lasda
Nature Biotechnology 2004

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts